Gilead's partnership with generic manufacturers to lower the cost of its HIV drug lenacapavir is criticized for being too ...

Exciting news for entrepreneurs and fans of innovation — Shark Tank India is back for Season 4, with the shooting officially underway! The much-anticipated reality series, known for bringing Indian ...

Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...

On Thursday, 1120 stocks advanced, 2864 declined and 92 remained unchanged, with an advance decline ratio 0.39 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader ...

Shark Tank India’s former co-judge Ashneer Grover is not new to controversies. Lets look at three instances where he got ...

Share Market Updates - Find here all the updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets ...

Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...

Emcure Pharmaceuticals on Thursday said it has signed a royalty-free voluntary licensing agreement with Gilead Sciences ...

Emcure Pharmaceuticals has partnered with Gilead Sciences to produce and distribute generic lenacapavir, an HIV treatment ...

Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...